• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学整合用于神经母细胞瘤临床终点预测。

Multi-omics integration for neuroblastoma clinical endpoint prediction.

机构信息

Fondazione Bruno Kessler, Via Sommarive 18, Trento, 38123, Italy.

Centre for Integrative Biology, University of Trento, Via Sommarive 9, Trento, 38123, Italy.

出版信息

Biol Direct. 2018 Apr 3;13(1):5. doi: 10.1186/s13062-018-0207-8.

DOI:10.1186/s13062-018-0207-8
PMID:29615097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5907722/
Abstract

BACKGROUND

High-throughput methodologies such as microarrays and next-generation sequencing are routinely used in cancer research, generating complex data at different omics layers. The effective integration of omics data could provide a broader insight into the mechanisms of cancer biology, helping researchers and clinicians to develop personalized therapies.

RESULTS

In the context of CAMDA 2017 Neuroblastoma Data Integration challenge, we explore the use of Integrative Network Fusion (INF), a bioinformatics framework combining a similarity network fusion with machine learning for the integration of multiple omics data. We apply the INF framework for the prediction of neuroblastoma patient outcome, integrating RNA-Seq, microarray and array comparative genomic hybridization data. We additionally explore the use of autoencoders as a method to integrate microarray expression and copy number data.

CONCLUSIONS

The INF method is effective for the integration of multiple data sources providing compact feature signatures for patient classification with performances comparable to other methods. Latent space representation of the integrated data provided by the autoencoder approach gives promising results, both by improving classification on survival endpoints and by providing means to discover two groups of patients characterized by distinct overall survival (OS) curves.

REVIEWERS

This article was reviewed by Djork-Arné Clevert and Tieliu Shi.

摘要

背景

高通量方法,如微阵列和下一代测序,在癌症研究中经常被使用,在不同的组学层面上生成复杂的数据。组学数据的有效整合可以更深入地了解癌症生物学的机制,帮助研究人员和临床医生开发个性化的治疗方法。

结果

在 CAMDA 2017 神经母细胞瘤数据整合挑战赛的背景下,我们探索了整合网络融合(INF)的使用,这是一个将相似网络融合与机器学习相结合的生物信息学框架,用于整合多个组学数据。我们应用 INF 框架来预测神经母细胞瘤患者的预后,整合了 RNA-Seq、微阵列和阵列比较基因组杂交数据。我们还探索了使用自动编码器作为整合微阵列表达和拷贝数数据的方法。

结论

INF 方法对于整合多个数据源是有效的,它为患者分类提供了紧凑的特征签名,其性能可与其他方法相媲美。自动编码器方法提供的集成数据的潜在空间表示给出了有希望的结果,不仅通过改善生存终点的分类,而且通过提供发现两组具有不同总体生存(OS)曲线的患者的手段。

审稿人

本文由 Djork-Arné Clevert 和 Tieliu Shi 审稿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/f9cddad0dca9/13062_2018_207_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/d834df673541/13062_2018_207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/372e8ffb133e/13062_2018_207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/cc595cdee0c7/13062_2018_207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/f2ef94b9730e/13062_2018_207_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/f9cddad0dca9/13062_2018_207_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/d834df673541/13062_2018_207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/372e8ffb133e/13062_2018_207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/cc595cdee0c7/13062_2018_207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/f2ef94b9730e/13062_2018_207_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8c/5907722/f9cddad0dca9/13062_2018_207_Fig5_HTML.jpg

相似文献

1
Multi-omics integration for neuroblastoma clinical endpoint prediction.多组学整合用于神经母细胞瘤临床终点预测。
Biol Direct. 2018 Apr 3;13(1):5. doi: 10.1186/s13062-018-0207-8.
2
A novel framework for horizontal and vertical data integration in cancer studies with application to survival time prediction models.一种用于癌症研究中水平和垂直数据集成的新框架及其在生存时间预测模型中的应用。
Biol Direct. 2019 Nov 21;14(1):22. doi: 10.1186/s13062-019-0249-6.
3
Robust pathway-based multi-omics data integration using directed random walks for survival prediction in multiple cancer studies.基于有向随机游走的稳健通路多组学数据整合用于多种癌症研究的生存预测。
Biol Direct. 2019 Apr 29;14(1):8. doi: 10.1186/s13062-019-0239-8.
4
A hierarchical integration deep flexible neural forest framework for cancer subtype classification by integrating multi-omics data.一种通过整合多组学数据进行癌症亚型分类的层次化集成深度灵活神经森林框架。
BMC Bioinformatics. 2019 Oct 28;20(1):527. doi: 10.1186/s12859-019-3116-7.
5
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.整合组学揭示MYCN作为细胞信号传导的全局抑制因子,并助力基于网络的神经母细胞瘤治疗靶点发现。
Oncotarget. 2015 Dec 22;6(41):43182-201. doi: 10.18632/oncotarget.6568.
6
Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.基于深度学习的多组学生物标志物数据特征层融合在乳腺癌患者生存分析中的应用。
BMC Med Inform Decis Mak. 2020 Sep 15;20(1):225. doi: 10.1186/s12911-020-01225-8.
7
Predicting clinical outcomes in neuroblastoma with genomic data integration.基于基因组数据整合预测神经母细胞瘤的临床结局。
Biol Direct. 2018 Sep 27;13(1):20. doi: 10.1186/s13062-018-0223-8.
8
Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling.整合网络融合:分子谱分析中的多组学方法
Front Oncol. 2020 Jun 30;10:1065. doi: 10.3389/fonc.2020.01065. eCollection 2020.
9
Network-based integration of multi-omics data for clinical outcome prediction in neuroblastoma.基于网络的多组学数据整合用于神经母细胞瘤的临床预后预测。
Sci Rep. 2022 Sep 14;12(1):15425. doi: 10.1038/s41598-022-19019-5.
10
Predicting clinical outcome of neuroblastoma patients using an integrative network-based approach.基于整合网络的方法预测神经母细胞瘤患者的临床预后。
Biol Direct. 2018 Jun 7;13(1):12. doi: 10.1186/s13062-018-0214-9.

引用本文的文献

1
DBSCAN and DBCV application to open medical records heterogeneous data for identifying clinically significant clusters of patients with neuroblastoma.DBSCAN和DBCV在开放医疗记录异构数据中的应用,用于识别神经母细胞瘤患者具有临床意义的聚类。
BioData Min. 2025 Jun 12;18(1):40. doi: 10.1186/s13040-025-00455-8.
2
A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework.基于网络的多组学方法在神经母细胞瘤生物标志物发现中的应用
NPJ Syst Biol Appl. 2024 May 17;10(1):52. doi: 10.1038/s41540-024-00371-3.
3
Systems Biology in Cancer Diagnosis Integrating Omics Technologies and Artificial Intelligence to Support Physician Decision Making.

本文引用的文献

1
Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.基于深度学习的多组学整合可稳健预测肝癌患者的生存情况。
Clin Cancer Res. 2018 Mar 15;24(6):1248-1259. doi: 10.1158/1078-0432.CCR-17-0853. Epub 2017 Oct 5.
2
Neuroblastoma treatment in the post-genomic era.后基因组时代的神经母细胞瘤治疗
J Biomed Sci. 2017 Feb 8;24(1):14. doi: 10.1186/s12929-017-0319-y.
3
Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.神经母细胞瘤,儿科肿瘤学大数据科学的一个范例。
癌症诊断中的系统生物学:整合组学技术与人工智能以支持医生决策
J Pers Med. 2023 Nov 10;13(11):1590. doi: 10.3390/jpm13111590.
4
Molecular Cluster Mining of Adrenocortical Carcinoma via Multi-Omics Data Analysis Aids Precise Clinical Therapy.多组学数据分析助力肾上腺皮质癌的分子聚类挖掘实现精准临床治疗。
Cells. 2022 Nov 26;11(23):3784. doi: 10.3390/cells11233784.
5
ViLoN-a multi-layer network approach to data integration demonstrated for patient stratification.ViLoN——一种用于数据集成的多层网络方法,用于患者分层。
Nucleic Acids Res. 2023 Jan 11;51(1):e6. doi: 10.1093/nar/gkac988.
6
Ten simple rules for organizing a special session at a scientific conference.组织科学会议特别会议的十个简单规则。
PLoS Comput Biol. 2022 Aug 25;18(8):e1010395. doi: 10.1371/journal.pcbi.1010395. eCollection 2022 Aug.
7
Advances in proteomic profiling of pediatric kidney diseases.儿科肾脏疾病蛋白质组学分析的进展。
Pediatr Nephrol. 2022 Oct;37(10):2255-2265. doi: 10.1007/s00467-022-05497-2. Epub 2022 Feb 26.
8
Toxicokinetics of Arenobufagin and its Cardiotoxicity Mechanism Exploration Based on Lipidomics and Proteomics Approaches in Rats.基于脂质组学和蛋白质组学方法对大鼠进行蟾毒灵的毒代动力学及其心脏毒性机制探索
Front Pharmacol. 2021 Dec 22;12:780016. doi: 10.3389/fphar.2021.780016. eCollection 2021.
9
The ZNF750-RAC1 axis as potential prognostic factor for breast cancer.ZNF750-RAC1轴作为乳腺癌潜在的预后因素。
Cell Death Discov. 2020 Nov 29;6(1):135. doi: 10.1038/s41420-020-00371-2.
10
Liquid biopsies and cancer omics.液体活检与癌症组学
Cell Death Discov. 2020 Nov 26;6(1):131. doi: 10.1038/s41420-020-00373-0.
Int J Mol Sci. 2016 Dec 27;18(1):37. doi: 10.3390/ijms18010037.
4
Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.神经母细胞瘤的近期生物学和遗传学进展:对诊断、风险分层及治疗策略的影响
Semin Pediatr Surg. 2016 Oct;25(5):257-264. doi: 10.1053/j.sempedsurg.2016.09.007. Epub 2016 Sep 28.
5
rCGH: a comprehensive array-based genomic profile platform for precision medicine.基于阵列的全基因组图谱平台rCGH用于精准医学。
Bioinformatics. 2016 May 1;32(9):1402-4. doi: 10.1093/bioinformatics/btv718. Epub 2015 Dec 26.
6
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.用于临床终点预测的RNA测序和基于微阵列模型的比较。
Genome Biol. 2015 Jun 25;16(1):133. doi: 10.1186/s13059-015-0694-1.
7
limma powers differential expression analyses for RNA-sequencing and microarray studies.limma为RNA测序和微阵列研究提供差异表达分析的动力。
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.
8
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium.测序质量控制联盟对RNA测序准确性、可重复性和信息含量的全面评估。
Nat Biotechnol. 2014 Sep;32(9):903-14. doi: 10.1038/nbt.2957. Epub 2014 Aug 24.
9
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma.在高分辨率阵列比较基因组杂交中,17号染色体/17q获得及未改变的图谱在神经母细胞瘤的预后判断中具有信息价值。
Genes Chromosomes Cancer. 2014 Aug;53(8):639-49. doi: 10.1002/gcc.22174. Epub 2014 Apr 15.
10
Childhood and adolescent cancer statistics, 2014.儿童和青少年癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103. doi: 10.3322/caac.21219. Epub 2014 Jan 31.